Search

Your search keyword '"Yves Humblet"' showing total 5 results
Start Over Author "Yves Humblet" Journal european journal of cancer supplements
5 results on '"Yves Humblet"'

1. 10LBA Randomized phase 3 study of panitumumab with FOLFOX4 compared to FOLFOX4 alone as 1st-line treatment (tx) for metastatic colorectal cancer (mCRC): the PRIME trial

Author

Yves Humblet, Salvatore Siena, Mario Edmundo Barugel, Ronald Burkes, Jim Cassidy, David Cunningham, J. Tabernero, Michael S. Wolf, Jean-Yves Douillard, and Jennifer Gansert

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Colorectal cancer, business.industry, Phases of clinical research, medicine.disease, Prime (order theory), Internal medicine, medicine, Panitumumab, Line (text file), business, medicine.drug
Published
2009
Full Text
View/download PDF

2. 98 POSTER DUSP4 expression level in colorectal primaries predicts overall survival benefit in Kras wild-type and Kras mutant colorectal cancer after treatment with cetuximab for metastatic disease

Author

Marc Peeters, Bart Jacobs, E. Van Cutsem, Bart Biesmans, J. De Schutter, W. De Roock, Sabine Tejpar, Yves Humblet, M. Janssens, and Peter Marynen

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Cetuximab, Colorectal cancer, business.industry, Mutant, Wild type, Disease, medicine.disease_cause, medicine.disease, Internal medicine, medicine, Overall survival, KRAS, business, After treatment, medicine.drug
Published
2008
Full Text
View/download PDF

3. 92 POSTER Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition

Author

J. De Schutter, Bart Jacobs, R Van Oirbeek, E. Van Cutsem, Bart Biesmans, W. De Roock, Marc Peeters, Yves Humblet, S. Fieuws, and Sabine Tejpar

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Amphiregulin, business.industry, Colorectal cancer, Internal medicine, Egfr inhibition, medicine, business, medicine.disease, Epiregulin
Published
2008
Full Text
View/download PDF

4. 3017 POSTER Cetuximab dose-escalation in patients (pts) with metastatic colorectal cancer (mCRC) with no or slight skin reactions on standard treatment: pharmacokinetic (PK), pharmacodynamic (PD) and efficacy data from the EVEREST study

Author

O. Kisker, Frédéric Viret, Yves Humblet, H. Gelderblom, Fortunato Ciardiello, Bengt Glimelius, E. Van Cutsem, Marc Peeters, Jan B. Vermorken, and Elisa Gallerani

Subjects
Oncology, Cancer Research, medicine.medical_specialty, Cetuximab, business.industry, Colorectal cancer, Standard treatment, medicine.disease, Skin reaction, Pharmacokinetics, Pharmacodynamics, Internal medicine, medicine, Dose escalation, In patient, business, medicine.drug
Published
2007
Full Text
View/download PDF

5. 260 A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma: the RadiOxCape study

Author

Bernard Coster, Jean-Charles Coche, B. Honhon, J-L Canon, Lionel Duck, Pierre Scalliet, J.-P. Machiels, C. Sempoux, Yves Humblet, and A. Kartheuser

Subjects
Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Locally advanced, Phases of clinical research, Oxaliplatin, Capecitabine, Internal medicine, medicine, Rectal Adenocarcinoma, In patient, Radiology, External beam radiotherapy, business, medicine.drug
Published
2003
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results